20:35 , Feb 3, 2017 |  BC Week In Review  |  Company News

Scancell, Bonnie J. Addario Lung Cancer Foundation, Addario Lung Cancer Medical Institute deal

Scancell and the nonprofits partnered to conduct a Phase I/II trial of Scancell's SCIB2 in patients with non-small cell lung cancer (NSCLC). The trial will start in 2018 and will be completed about 18 months...
07:00 , Oct 13, 2016 |  BC Innovations  |  Strategy

Exosomes in the zone

Mark Zipkin, Staff Writer  Having had a slow on-ramp to recognition as more than cellular garbage bags, exosomes are gaining status as a potentially transformational technology, with utility in both diagnostics and therapeutics. But the...
07:00 , Aug 18, 2014 |  BC Week In Review  |  Clinical News

FoundationOne: Clinical trial started

Foundation Medicine said The Addario Lung Cancer Medical Institute (ALCMI) and Bonnie J. Addario Lung Cancer Foundation (ALCF) will use the company’s FoundationOne assay in the international Genomics of Young Lung Cancer study in about...
08:00 , Feb 25, 2013 |  BC Week In Review  |  Company News

Cancer Commons, Imerman Angels, Oregon Health & Science University, Science Exchange, The Bonnie J. Addario Lung Cancer Foundation, The Melanoma Research Founda

Cancer Commons, a not-for-profit open science initiative linking patients, physicians and researchers said six additional research centers, service providers and patient advocacy groups joined its "cancer ecosystem" Alliance. The Alliance is a pre-competitive group of...